tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI

Brainstorm Cell Therapeutics (BCLI) Similar Stocks

Compare
564 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Brainstorm Cell Therapeutics
$1.12
$8.42M
-79.10%
1 Buy
0 Hold
0 Sell
Moderate Buy
GT Biopharma
$3.54
$11.14M
34.59%
1 Buy
0 Hold
0 Sell
Moderate Buy
Genprex
$0.22
$6.47M
-88.24%
Aptorum Group
$0.91
$6.94M
49.73
-77.64%
Lyra Therapeutics
$9.11
$12.07M
-39.62%
0 Buy
3 Hold
0 Sell
Hold
Conduit Pharmaceuticals
$2.88
$2.18M
-99.82%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BCLI
Brainstorm Cell Therapeutics
1.12
-4.24
-79.10%
GTBP
GT Biopharma
3.58
0.92
34.59%
GNPX
Genprex
0.23
-1.70
-88.08%
APM
Aptorum Group
0.91
-3.16
-77.64%
LYRA
Lyra Therapeutics
8.96
-5.88
-39.62%
CDT
Conduit Pharmaceuticals
2.76
-1,489.89
-99.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis